Analysis of metabolic characteristics of metabolic syndrome in elderly patients with gastric cancer by non-targeted metabolomics

Table 1 Comparison of baseline data among groups, mean ± SD or n (%)

Group	Control group	Frailty group	MetS group	Merging group
N	125	50	65	50
Age (yr)	66.76 ± 5.16	73.30 ± 5.94a	67.08 ± 4.89	68.90 ± 6.33
BMI (kg/m2)	22.88 ± 2.10	22.48 ± 2.00	25.15 ± 3.15a	26.33 ± 3.33a
Female	7 (28.0)	4 (40.0)	4 (30.8)	5 (50.0)
Complication	10 (40.0)	7 (70.0)	13 (100.0)a	9 (90.0)a
Polypharmacy	1 (4.0)	0 (0.0)	3 (23.1)	1 (10.0)
NRS2002 ≥ 3	7 (28.0)	2 (20.0)	3 (23.1)	2 (20.0)
TNM III	9 (36.0)	5 (50.0)	4 (30.8)	7 (70.0)

^aP < 0.05.

MetS: Metabolic syndrome; BMI: Body mass index; TNM: Tumor-node-metastasis.